|
|
|
Insider
Information: |
Mather Charles E Iv |
Relationship: |
Director |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
98,068 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$70,765 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
98,068 |
|
|
Total
Value |
$70,765 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
4
|
1
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
3
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-20.1%
|
-42.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Tonix Pharmaceuticals Holding Corp |
TNXP |
Director |
2017-05-27 |
3,283 |
|
0 |
Premium* |
|
Eyenovia Inc |
EYEN |
Director |
2023-06-27 |
94,785 |
2018-07-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2013-01-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
150,569 |
|
- |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2013-09-04 |
4 |
B |
$3.23 |
$1,457 |
D/D |
451 |
9,230 |
2.31 |
- |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2013-09-09 |
4 |
B |
$3.48 |
$2,088 |
D/D |
600 |
9,830 |
2.31 |
- |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2016-02-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
600 |
1,783 |
0 |
- |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2017-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
750 |
2,533 |
0 |
- |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2017-05-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
750 |
3,283 |
0 |
- |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2013-09-27 |
4 |
B |
$3.65 |
$3,650 |
D/D |
1,000 |
10,830 |
2.31 |
- |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2015-03-10 |
4 |
B |
$6.80 |
$6,800 |
D/D |
1,000 |
11,830 |
2.39 |
- |
|
EYEN |
Eyenovia Inc |
Director |
|
2018-09-18 |
4 |
B |
$4.80 |
$4,800 |
D/D |
1,000 |
5,033 |
2.31 |
- |
|
EYEN |
Eyenovia Inc |
Director |
|
2018-09-19 |
4 |
B |
$4.78 |
$14,340 |
D/D |
3,000 |
8,033 |
2.39 |
- |
|
EYEN |
Eyenovia Inc |
Director |
|
2021-05-28 |
4 |
B |
$4.76 |
$14,268 |
D/D |
3,000 |
26,359 |
2.39 |
% |
|
EYEN |
Eyenovia Inc |
Director |
|
2023-05-26 |
4 |
B |
$2.49 |
$7,470 |
D/D |
3,000 |
77,544 |
2.39 |
% |
|
EYEN |
Eyenovia Inc |
|
|
2022-03-31 |
4 |
B |
$3.12 |
$12,460 |
D/D |
4,000 |
41,322 |
0.01 |
% |
|
EYEN |
Eyenovia Inc |
Director |
|
2023-05-15 |
4/A |
B |
$3.39 |
$13,560 |
D/D |
4,000 |
74,544 |
2.39 |
- |
|
EYEN |
Eyenovia Inc |
Director |
|
2023-05-15 |
4 |
S |
$3.39 |
$13,560 |
D/D |
(4,000) |
74,544 |
0 |
% |
|
EYEN |
Eyenovia Inc |
Director |
|
2018-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,033 |
4,033 |
0 |
- |
|
EYEN |
Eyenovia Inc |
|
|
2022-05-18 |
4 |
B |
$2.03 |
$14,232 |
D/D |
7,000 |
48,322 |
0.01 |
% |
|
EYEN |
Eyenovia Inc |
Director |
|
2020-09-11 |
4 |
A |
$0.00 |
$0 |
D/D |
7,288 |
23,359 |
0 |
- |
|
EYEN |
Eyenovia Inc |
Director |
|
2019-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
8,038 |
16,071 |
0 |
- |
|
EYEN |
Eyenovia Inc |
Director |
|
2023-06-27 |
4 |
A |
$0.00 |
$0 |
D/D |
17,241 |
94,785 |
0 |
- |
|
EYEN |
Eyenovia Inc |
|
|
2022-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
22,222 |
70,544 |
0 |
- |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2013-04-26 |
4 |
OE |
$0.40 |
$10,000 |
D/D |
25,000 |
175,569 |
0 |
- |
|
22 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|